Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2

OBJECTIVES: Metastatic melanoma patients with leptomeningeal disease (LMD) have an extremely poor prognosis, with a median survival measured in weeks, and few treatment options. Outcomes of a retrospective cohort of patients with LMD that were treated with intrathecal interleukin-2 (IT IL-2) were re...

Descripción completa

Detalles Bibliográficos
Autores principales: Glitza, Isabella C, Rohlfs, Michelle, Guha-Thakurta, Nandita, Bassett, Roland L, Bernatchez, Chantale, Diab, Adi, Woodman, Scott E, Yee, Cassian, Amaria, Rodabe N, Patel, Sapna P, Tawbi, Hussein, Wong, Michael, Hwu, Wen-Jen, Hwu, Patrick, Heimberger, Amy, McCutcheon, Ian E, Papadopoulos, Nicholas, Davies, Michael A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786950/
https://www.ncbi.nlm.nih.gov/pubmed/29387478
http://dx.doi.org/10.1136/esmoopen-2017-000283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786950/
https://www.ncbi.nlm.nih.gov/pubmed/29387478
http://dx.doi.org/10.1136/esmoopen-2017-000283

Ejemplares similares